18 results  1 of 1 

1 Expression of CD44 according to Clinicopathologic Characteristics of Gastric Cancer
Min Sun Ryu, Hee Jung Park, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim, Sung-Ae Jung, Min Sun Cho
Ewha Med J.2018;41(3):63-74.   Published online 2018 July 31     DOI: http://dx.doi.org/10.12771/emj.2018.41.3.63
      
2 CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
Feng Ye, Xiaorong Zhong, Yan Qiu, Libo Yang, Bing Wei, Zhang Zhang, Hong Bu
J Breast Cancer.2017;20(2):142-149.   Published online 2017 June 26     DOI: http://dx.doi.org/10.4048/jbc.2017.20.2.142
      
3 Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
Jörg U. Schmohl, Martin Felices, Felix Oh, Alexander J. Lenvik, Aaron M. Lebeau, Jayanth Panyam, Jeffrey S. Miller, Daniel A. Vallera
Cancer Res Treat.2017;49(4):1140-1152.   Published online 2017 February 20     DOI: http://dx.doi.org/10.4143/crt.2016.491
      
4 Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
Wanlu Li, Mi-Ra Lee, EunHee Choi, Mee-Yon Cho
J Pathol Transl Med.2017;51(1):17-23.   Published online 2016 December 15     DOI: http://dx.doi.org/10.4132/jptm.2016.09.23
      
5 Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell
Hyun-Gyo Lee, So-Jin Shin, Hye-Won Chung, Sang-Hoon Kwon, Soon-Do Cha, Jin-Eui Lee, Chi-Heum Cho
J Gynecol Oncol.2017;28(2):e14.  Published online 2016 November 14     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e14
      
6 The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma
Hyeon Jin Kim, Min-Jung Kim, Areumnuri Kim, Chang Won Jung, Sunhoo Park, Jae Soo Koh, Jae Kyung Myung
Cancer Res Treat.2017;49(2):509-517.   Published online 2016 September 1     DOI: http://dx.doi.org/10.4143/crt.2016.214
      
7 New Findings on Breast Cancer Stem Cells: A Review
Azam Bozorgi, Mozafar Khazaei, Mohammad Rasool Khazaei
J Breast Cancer.2015;18(4):303-312.   Published online 2015 December 23     DOI: http://dx.doi.org/10.4048/jbc.2015.18.4.303
      
8 Cancer Stem Cells: Biological Features and Targeted Therapeutics
Se Yong Song, Daekwan Seo
Hanyang Med Rev.2015;35(4):250-257.   Published online 2015 November 24     DOI: http://dx.doi.org/10.7599/hmr.2015.35.4.250
      
9 The Presence of EpCAM-/CD49f+ Cells in Breast Cancer Is Associated with a Poor Clinical Outcome
Feng Ye, Yan Qiu, Li Li, Libo Yang, Fei Cheng, Hongying Zhang, Bing Wei, Zhang Zhang, Linyong Sun, Hong Bu
J Breast Cancer.2015;18(3):242-248.   Published online 2015 September 24     DOI: http://dx.doi.org/10.4048/jbc.2015.18.3.242
      
10 CD44 expression in patients with combined hepatocellular cholangiocarcinoma
Ryounggo Kim, Sang Bum Kim, Eung-Ho Cho, Sun Hoo Park, Sung Bae Park, Seong Kweon Hong, Gibong Chae
Ann Surg Treat Res.2015;89(1):9-16.   Published online 2015 June 11     DOI: http://dx.doi.org/10.4174/astr.2015.89.1.9
      
11 Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines
Maryam Rahman, Karina Reyner, Loic Deleyrolle, Sebastien Millette, Hassan Azari, Bryan W. Day, Brett W. Stringer, Andrew W. Boyd, Terrance G. Johns, Vincent Blot, Rohit Duggal, Brent A. Reynolds
Anat Cell Biol.2015;48(1):25-35.   Published online 2015 March 20     DOI: http://dx.doi.org/10.5115/acb.2015.48.1.25
      
12 Clinicopathologic Characteristics of Breast Cancer Stem Cells Identified on the Basis of Aldehyde Dehydrogenase 1 Expression
Yoon Seok Kim, Min Jung Jung, Dong Won Ryu, Chung Han Lee
J Breast Cancer.2014;17(2):121-128.   Published online 2014 June 27     DOI: http://dx.doi.org/10.4048/jbc.2014.17.2.121
      
13 The Expression of Aldehyde Dehydrogenase Family in Breast Cancer
Yan Qiu, Tianjie Pu, Li Li, Fei Cheng, Changli Lu, Linyong Sun, Xiao Teng, Feng Ye, Hong Bu
J Breast Cancer.2014;17(1):54-60.   Published online 2014 March 28     DOI: http://dx.doi.org/10.4048/jbc.2014.17.1.54
      
14 The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines
Sabrieh Amini, Fardin Fathi, Jafar Mobalegi, Heshmatollah Sofimajidpour, Tayyeb Ghadimi
Anat Cell Biol.2014;47(1):1-11.   Published online 2014 March 13     DOI: http://dx.doi.org/10.5115/acb.2014.47.1.1
      
15 Reactive Oxygen Species and Cancer
Inpyo Choi
Hanyang Med Rev.2013;33(2):118-122.   Published online 2013 May 23     DOI: http://dx.doi.org/10.7599/hmr.2013.33.2.118
      
16 Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis
Maurizio Di Bonito, Francesca Collina, Monica Cantile, Rosalba Camerlingo, Margherita Cerrone, Laura Marra, Giuseppina Liguori, Giuseppe Pirozzi, Gerardo Botti
J Breast Cancer.2012;15(1):15-23.   Published online 2012 March 28     DOI: http://dx.doi.org/10.4048/jbc.2012.15.1.15
      
17 Cancer stem cell theory and update in oral squamous cell carcinoma
Deok-Hun Kim, Jun-Yong Yun, Ju-Hyun Lee, Hoon Myoung, Soung-Min Kim
J Korean Assoc Oral Maxillofac Surg.2011;37(2):97-108.   Published online 2011 January 10     DOI: http://dx.doi.org/10.5125/jkaoms.2011.37.2.97
   
18 Differential Expression of Stem Cell Markers and Vascular Endothelial Growth Factor in Human Retinoblastoma Tissue
Martha Kim, Jeong Hun Kim, Jin Hyoung Kim, Dong Hun Kim, Young Suk Yu
Korean J Ophthalmol.2010;24(1):35-39.   Published online 2010 February 5     DOI: http://dx.doi.org/10.3341/kjo.2010.24.1.35
      

 1 of 1